The Reactivation of X-linked Tumor Suppressor Gene FOXP3 by Anisomycin and Xist Small Interfering RNA in Breast Cancer Cells
ISEF · 2014 Computational Biology and Bioinformatics
Overview
The FOXP3 gene on the X-chromosome is responsible for the development and function of regulatory T cells. Our previous studies found that FOXP3 also behaves as an X-linked tumor suppressor identified in breast cancer. This fact was proven by the discovery that 1. FOXP3 is inactivated in most of breast cancer tissues; 2. it can inhibit breast tumor growth. This study investigates the mechanisms of FOXP3 inactivation and develops the reactivation strategy of FOXP3 gene in breast cancer cells. By using pyrosequencing, I identified a hypermethylation site at the 5’ CpG island of the FOXP3 promoter in breast cancer cells. Surprisingly, a significant increase of methylation in the CpG island strongly correlates to a reduction of FOXP3 expression in breast cancer cells; it does not, however, share similar associations with the T-regulatory cell specific demethylated region (TSDR). In contrast, both the CpG island and TSDR were nearly 100% methylated in Jurkat T cells. Thus, the 5’ CpG island appears to be a critical methylation site which may involve epigenetic regulation during the inactivation of FOXP3 in breast cancer cells. In particular, I demonstrated that anisomycin, an anticancer drug, can prompt FOXP3 expression by decreasing DNA methylation of FOXP3. Notably, a non-coding Xist small interfering RNA (siRNA) remarkably enhances anisomycin-induced FOXP3 expression. My data suggested that FOXP3 inactivation may be caused by DNA methylation; essentially, FOXP3 inactivation can be reactivated by anisomycin with Xist siRNA, suggesting a novel therapeutic strategy for breast cancer patients with FOXP3 defects.
Competition history
- ISEF 2014
Resources
Related projects
ISEF · 2022
Genes Negatively Regulated by FOXO1 and Their Association With Breast Cancer
ISEF · 2018
X Chromosome Inactivation in Pluripotent Stem Cells
ISEF · 2025
RNAi Therapy in Cancer Treatment II
ISEF · 2014
Characterization of Gene Expression in p53 Activated Tumor-Initiating Cells
ISEF · 2014
Overcoming Resistance
ISEF · 2016
Can APOBEC3B Be a Therapeutic Target for Breast Cancer?
ISEF · 2018
Investigating Whether FOXO1 Hinders ZEB1 Gene Expression in (U87MG) Glioblastoma Cells
ISEF · 2023
The Effect of Immune Checkpoint Inhibitor Ipilimumab on the Development and Proliferation of Breast Cancer Stem Cells
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair